El sermón de Montesinos y las Leyes de Burgos

Managing Board

Feike Sijbesma (1959, m), chairman

Position: chairman of DSM’s Managing Board since May 2007;

member of DSM’s Managing Board since July 2000.

Nationality: Dutch.

Supervisory directorships and other positions held: board

member of Cefic (European Chemical Industry Council), member of the Supervisory Board of Utrecht University (Netherlands) and the Supervisory Board of the Dutch Genomics Initiative, member of the Dutch Innovation Platform 2.0, member of the Advisory Board of RSM Erasmus University and of ECP.NL.

e-mail: [email protected] Rolf-Dieter Schwalb (1952, m), CFO

Position: member of DSM’s Managing Board and CFO since

October 2006.

Nationality: German.

Supervisory directorships and other positions held: None.

e-mail: [email protected] Nico Gerardu (1951, m)

Position: member of DSM’s Managing Board since April 2006. Nationality: Dutch.

Supervisory directorships and other positions held: member of

the Supervisory Board of Voestalpine Polynorm N.V. and the Bonnefanten Museum in Maastricht (Netherlands) and chairman of the Supervisory Board of Holland Colours N.V.

e-mail: [email protected] Stephan Tanda (1965, m)

Position: member of DSM’s Managing Board since May 2007. Nationality: Austrian.

Supervisory directorships and other positions held: board

member of EuropaBio (European Biotechnology Industries Association), SGCI (Swiss Chemical and Pharmaceutical Industry Association) and ACC (American Chemistry Council). e-mail: [email protected]

DSM Leadership Council

(as of 1 January 2010)

Directors of business groups

DSM Nutritional Products Leendert Staal (1953)

- Human Nutrition and Health

Mauricio Adade1

(1963)

- Animal Nutrition and Health

Antonio-Ruy Freire

(1949)

DSM Food Specialties Alexander Wessels (1964)

DSM Pharmaceutical

Products Bob Hartmayer (1952)

DSM Anti-Infectives Stefan Doboczky (1967)

DSM Engineering Plastics Roelof Westerbeek (1963)

DSM Dyneema Christophe Dardel2 ₍₁₉₆₀₎

DSM Resins Ben van Kooten (1951)

DSM Fibre Intermediates Edward Sheu (1953)

DSM Agro Renso Zwiers (1955)

DSM Melamine Anton Robek (1959)

DSM Elastomers Jan Paul de Vries (1958)

Directors of Corporate Staff Departments

Corporate Secretariat Femke Weijtens (1967)

Control & Accounting Loek Radix (1956)

Human Resources Paul Jarrell (1962)

Strategy & Acquisitions Hein Schreuder (1951)

Communications Angelique Paulussen (1959)

Legal Affairs Pieter de Haan (1954)

Operational Audit Hans van Suijdam (1950)

Strategic Projects Ben van Dijk (1951)

Strategic Projects Gerard de Reuver2 ₍₁₉₅₆₎ Directors of Functional Excellence Departments

DSM Innovation Center Rob van Leen (1957)

Marketing Vacancy1 _-

Operations and Responsible Care

Luca Rosetto

(1963)

Directors of Shared Services Departments

ICT Aloys Kregting (1967)

Sourcing Tim Tolhurst (1961)

DSM Expert Center Jos Goessens (1951)

Directors of Regions / Countries

DSM Netherlands Jos Schneiders (1951)

DSM China Wei-Ming Jiang (1956)

1 _{Mr. Mauricio Adade has been appointed Chief Marketing}

succeed Mauricio Adade as President HNH of DSM Nutritional Products with effect from 1 May 2010

2 _{Mr. Gerard de Reuver has been appointed business group}

director DSM Dyneema with effect from 1 April 2010.

Mr. Christophe Dardel, at present business group director DSM Dyneema, has been appointed President of DSM Biomedical with effect from 15 May 2010.

Shares and listings

Ordinary shares in Royal DSM N.V. are listed on the Euronext stock exchange in Amsterdam, the Netherlands (Stock code 00982, ISIN code NL0000009827).

Options on ordinary DSM shares are traded on the European Option Exchange in Amsterdam, the Netherlands (Euronext.liffe). In the United States a sponsored unlisted American Depositary Receipts (ADR) program is offered by Citibank NA

(Cusip 780249108), with four ADRs representing the value of one ordinary DSM share.

Besides the ordinary shares, 44.04 million cumulative preference shares A are in issue, which are not listed on the stock exchange; these have been placed with institutional investors. The cumprefs A have the same voting rights as ordinary shares, as

their nominal value of € 1.50 per share is equal to the nominal value of the ordinary shares.

Transfer of the cumprefs A requires the approval of the Managing Board, unless the shareholder is obliged to transfer his shares to a previous shareholder by virtue of the law.

In 2009 the Annual General Meeting of Shareholders approved an amendment to remove the cumulative preference shares C from the Articles of Association.

The average number of ordinary shares outstanding in 2009 was 162,364,142. All shares in issue are fully paid.

On 31 December 2009 the company had 163,037,329 shares outstanding.

Development of the number of ordinary DSM shares

2009 2008

Issued Repurchased Outstanding Outstanding

Balance at 1 January 181,425,000 19,197,938 162,227,062 166,896,860

Changes:

Reissue of shares in connection with exercise of option rights - (810,267) 810,267 1,945,202

Repurchase of own shares - - - (6,615,000)

Balance at 31 December 181,425,000 18,387,671 163,037,329 162,227,062

DSM share prices on Euronext Amsterdam (€ per ordinary share):

Highest closing price 34.84 41.27

Lowest closing price 16.93 15.76

At 31 December 34.46 18.33

Dividend Re-Investment Plan for shareholders of Royal DSM N.V.

ABN AMRO Bank N.V. offers DSM’s shareholders the option of participating in a Dividend Re-Investment Plan (DRIP). By participating in this plan, DSM shareholders are able to directly reinvest their net dividends in additional DSM shares.

DSM Managing Board members’ holdings in DSM shares

The cumulative holdings of the four DSM Managing Board members increased in 2009 from 20,604 to 32,056 shares on 1 January 2010. These shareholdings serve as a long-term investment in the company. These share purchases were private transactions with private money. The holdings do not include vested performance shares.

Board member Holdings on 1 January 2010

Holdings on 1 January 2009

Feike Sijbesma, chairman / CEO 14,000 5,500

Rolf-Dieter Schwalb, CFO 7,000 5,500

Nico Gerardu 5,056 5,056

Stephan Tanda 6,000 4,548